semaglutide in heart failure patients with cardiometabolic #HFpEF, #semaglutide and #tirzepatide reduced the risk of hospitalization for or all-cause mortality compared to sitagliptin, but tirzepatide offered no additional benefit over semaglutide. #ESCCongress Semaglutide ameliorates pressure overload-induced cardiac

Vial size and reconstitution volume together determine the final concentration, which determines the syringe volume for each target dose

It signals the pancreas to release insulin, slows gastric emptying so food stays in the stomach longer, and communicates with the brain appetite centers to reduce hunger

Basal oxygen consumption rate (OCR) and extracellular acidification rate (ECAR) were determined

A licensed provider reviews your information, determines whether GLP-1 treatment is appropriate, and prescribes accordingly

It works alongside lifestyle changes rather than instead of them, so you'll need to commit to a reduced calorie diet and increased physical activity to get the best from it

The Discontinuation Problem Nobody Talks About Clinical trials for GLP-1 medications show promising results, with patients losing 15-21% of their excess body weight